Charles River Laboratories reported $169.84M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Align Technology ALGN:US $ 261.99M 6.81M
Allscripts Healthcare Solutions MDRX:US $ 45.5M 2.1M
Amerisourcebergen ABC:US $ 637.71M 60.52M
Anthem ANTM:US $ 2210M 84M
Bio Rad Laboratories BIO:US $ 136.82M 0.96M
Bruker BRKR:US $ 121M 27.8M
Galapagos GLPG:NA € -64.46M 0.5M
Illumina ILMN:US $ 254M 82M
Intrexon XON:US $ -29.88M 9.76M
IQVIA Holdings Inc IQV:US $ 533M 8M
Laboratory Of America LH:US $ 842.8M 38.1M
Lonza Group LONN:SW 496.49M 151.49M
Mckesson MCK:US $ 1233M 188M
Novartis NOVN:VX SF 4544M 120M
Quest Diagnostics DGX:US $ 696M 142M
United Therapeutics UTHR:US $ 204.4M 12.1M
UnitedHealth UNH:US $ 5595M 278M